Back
Unity Biotechnology Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
23
UBX
Unity Biotechnology
Last Price:
$0.78
Seasonality Move:
-0.35%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UBX is experiencing slight buying pressure.
Unity Biotechnology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.86 | Sell |
20-day SMA: | 0.96 | Sell |
50-day SMA: | 1.17 | Sell |
200-day SMA: | 1.42 | Sell |
8-day EMA: | 0.85 | Sell |
20-day EMA: | 0.94 | Sell |
50-day EMA: | 1.14 | Sell |
200-day EMA: | 1.43 | Sell |
Unity Biotechnology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 30.33 | Sell |
Chaikin Money Flow: | 45329 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.87 - 1.05) | Sell |
Bollinger Bands (100): | (0.98 - 1.96) | Sell |
Unity Biotechnology Technical Analysis
May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Unity Biotechnology Stock
Is Unity Biotechnology Stock a Buy?
-
Unity Biotechnology share price is 0.76 while UBX 8-day simple moving average is 0.86, which is a Sell signal.
-
The stock price of UBX is 0.76 while Unity Biotechnology 20-day SMA is 0.96, which makes it a Sell.
-
Unity Biotechnology 50-day simple moving average is 1.17 while UBX share price is 0.76, making it a Sell technically.
-
UBX stock price is 0.76 and Unity Biotechnology 200-day simple moving average is 1.42, creating a Sell signal.
UBX Technical Analysis vs Fundamental Analysis
Sell
23
Unity Biotechnology (UBX)
is a Sell
Is Unity Biotechnology a Buy or a Sell?
-
Unity Biotechnology stock is rated a SellThe current Unity Biotechnology [UBX] share price is $0.76. The Score for UBX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Unity Biotechnology Stock Info
Market Cap:
13.1M
Price in USD:
0.76
Share Volume:
202.5K
Unity Biotechnology 52-Week Range
52-Week High:
3.10
52-Week Low:
0.70
Sell
23
Unity Biotechnology (UBX)
is a Sell
Unity Biotechnology Share Price Forecast
-
What is the Unity Biotechnology stock price today?The Unity Biotechnology stock price is 0.76 USD today.
-
Will UBX stock go up or go down?Unity Biotechnology> share price is forecast to RISE/FALL based on technical indicators
-
Is Unity Biotechnology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Unity Biotechnology is overvalued.
Is Unity Biotechnology Stock a Buy?
-
Unity Biotechnology share price is 0.76 while UBX 8-day exponential moving average is 0.85, which is a Sell signal.
-
The stock price of UBX is 0.76 while Unity Biotechnology 20-day EMA is 0.94, which makes it a Sell.
-
Unity Biotechnology 50-day exponential moving average is 1.14 while UBX share price is 0.76, making it a Sell technically.
-
UBX stock price is 0.76 and Unity Biotechnology 200-day simple moving average is 1.43, creating a Sell signal.
Fundamental Analysis of Unity Biotechnology
Is Unity Biotechnology a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.37 per share.
Technical Analysis of Unity Biotechnology
Should I short Unity Biotechnology stock?
-
UBX Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Unity Biotechnology is a Sell
-
Unity Biotechnology Relative Strength Index (RSI) is 30.33, which suggest Unity Biotechnology is oversold
-
The Bollinger Bands (25) for Unity Biotechnology is (0.87 - 1.05), which suggest Unity Biotechnology is a Sell
-
The Bollinger Bands (100) for Unity Biotechnology is (0.98 - 1.96), which suggest Unity Biotechnology is a Sell
* Unity Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.